SRCAP

Snf2 related CREBBP activator protein, the group of Small nucleolar RNA protein coding host genes|SRCAP complex

Basic information

Region (hg38): 16:30698209-30741409

Links

ENSG00000080603NCBI:10847OMIM:611421HGNC:16974Uniprot:Q6ZRS2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Floating-Harbor syndrome (Definitive), mode of inheritance: AD
  • Floating-Harbor syndrome (Supportive), mode of inheritance: AD
  • Floating-Harbor syndrome (Definitive), mode of inheritance: AD
  • developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities (Definitive), mode of inheritance: AD
  • developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities (Strong), mode of inheritance: AD
  • Floating-Harbor syndrome (Strong), mode of inheritance: AD
  • Floating-Harbor syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Floating-Harbor syndrome; Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalitiesADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Genitourinary; Musculoskeletal; Neurologic7588969; 16523514; 20358590; 22265015; 23763483; 33909990

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SRCAP gene.

  • not provided (24 variants)
  • Floating-Harbor syndrome (5 variants)
  • Inborn genetic diseases (5 variants)
  • Neurodevelopmental disorder (3 variants)
  • Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities (2 variants)
  • Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities;Floating-Harbor syndrome (2 variants)
  • Neurodevelopmental delay (1 variants)
  • SRCAP-related disorder (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRCAP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
352
clinvar
14
clinvar
372
missense
2
clinvar
652
clinvar
72
clinvar
6
clinvar
732
nonsense
11
clinvar
8
clinvar
5
clinvar
24
start loss
0
frameshift
21
clinvar
11
clinvar
3
clinvar
35
inframe indel
19
clinvar
4
clinvar
23
splice donor/acceptor (+/-2bp)
1
clinvar
3
clinvar
4
splice region
15
27
3
45
non coding
3
clinvar
74
clinvar
24
clinvar
101
Total 32 22 691 502 44

Variants in SRCAP

This is a list of pathogenic ClinVar variants found in the SRCAP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-30699243-G-T Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities Uncertain significance (Sep 20, 2023)2580156
16-30700361-A-C Benign (Nov 12, 2018)1281215
16-30700467-G-C Benign (May 15, 2021)1268985
16-30700615-G-C Uncertain significance (Nov 28, 2022)2503177
16-30700835-G-A Uncertain significance (Dec 16, 2021)1691743
16-30700842-C-T Likely benign (May 06, 2022)1932238
16-30700847-C-G Uncertain significance (Apr 14, 2021)1387471
16-30700857-G-A Likely benign (May 13, 2023)2960864
16-30700867-C-G Uncertain significance (Feb 15, 2021)1486146
16-30700869-A-G Likely benign (Sep 23, 2022)2181137
16-30700873-A-G Uncertain significance (May 22, 2023)2867100
16-30700895-A-T Likely benign (Sep 10, 2023)2806009
16-30700951-G-T Benign (Jul 23, 2021)1304879
16-30701000-C-A Benign (Jul 23, 2021)1304889
16-30701084-C-T Benign (May 17, 2021)1251888
16-30703955-A-C Benign (Jul 23, 2021)1304897
16-30704044-A-G Likely benign (Oct 13, 2022)1540261
16-30704047-A-G not specified Likely benign (May 30, 2024)3336598
16-30704050-T-G Likely benign (Oct 13, 2023)2968782
16-30704052-C-T Likely benign (Aug 17, 2023)2984970
16-30704055-C-T Likely benign (Nov 23, 2022)740799
16-30704063-G-A Neurodevelopmental disorder Likely pathogenic (Jan 10, 2021)995426
16-30704071-C-T Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities;Floating-Harbor syndrome • Inborn genetic diseases Conflicting classifications of pathogenicity (Jan 04, 2024)197283
16-30704072-G-A Likely benign (Apr 14, 2023)2086282
16-30704074-A-G Uncertain significance (Dec 05, 2022)2504377

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SRCAPprotein_codingprotein_codingENST00000262518 3246073
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.002.73e-161257320161257480.0000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.1316341.89e+30.8620.00011820343
Missense in Polyphen147225.750.651172176
Synonymous-3.118507421.150.00004197482
Loss of Function9.8161240.04850.000007541310

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001850.000185
Ashkenazi Jewish0.0001990.000198
East Asian0.000.00
Finnish0.00004640.0000462
European (Non-Finnish)0.00007090.0000615
Middle Eastern0.000.00
South Asian0.00009810.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalytic component of the SRCAP complex which mediates the ATP-dependent exchange of histone H2AZ/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling. Acts as a coactivator for CREB-mediated transcription, steroid receptor-mediated transcription, and Notch-mediated transcription. {ECO:0000269|PubMed:10347196, ECO:0000269|PubMed:11522779, ECO:0000269|PubMed:14500758, ECO:0000269|PubMed:16024792, ECO:0000269|PubMed:16634648, ECO:0000269|PubMed:17617668}.;
Disease
DISEASE: Floating-Harbor syndrome (FLHS) [MIM:136140]: A rare genetic disorder characterized by proportionate short stature, delayed bone age, delayed speech development, and typical facial features. The face is triangular with deep-set eyes, long eyelashes, bulbous nose, wide columella, short philtrum, and thin lips. {ECO:0000269|PubMed:22265015}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Pathways Affected in Adenoid Cystic Carcinoma (Consensus)

Recessive Scores

pRec
0.0771

Intolerance Scores

loftool
0.00579
rvis_EVS
-4.14
rvis_percentile_EVS
0.15

Haploinsufficiency Scores

pHI
0.405
hipred
Y
hipred_score
0.630
ghis
0.626

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.847

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Srcap
Phenotype

Gene ontology

Biological process
chromatin remodeling;regulation of transcription by RNA polymerase II;viral process;gene silencing;histone acetylation;ATP-dependent chromatin remodeling;histone exchange;positive regulation of nucleic acid-templated transcription
Cellular component
Swr1 complex;nucleus;nucleoplasm;Golgi apparatus;nuclear body;protein-containing complex;perinuclear region of cytoplasm
Molecular function
DNA binding;transcription coactivator activity;helicase activity;histone acetyltransferase activity;protein binding;ATP binding;ATPase activity;histone binding